Home›Companies›Healthcare›Atlas Oncology Partners

Atlas Oncology Holdings Inc.

Provides care teams and cost-risk arrangements to community cancer practices.

Updated Nov 11, 2026·Latest SEC filing Feb 25, 2026·Suggest an edit

About Atlas Oncology Partners

Atlas Oncology Partners is a private company based in Nashville, Tennessee, incorporated in 2023 in Delaware. It has reported $23,000,000 raised in one offering on Form D since February 2026.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Feb 10, 2026Feb 25, 2026$23,000,000fully sold3$7.6MEquityRule 506(b)Form D ↗

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Atlas Oncology Partners's Form D filed Feb 25, 2026.

MK
Matt Kim
Partner at Rubicon Founders and director
DG
David Glaccum
Executive officer, director and promoter
Ian Chiang
Ian Chiang
Partner and director
Also a director at Rx Redefined and knownwell.
TN
Todd Nice
Executive officer and promoter
Kate Roberts
Kate Roberts
President & Co-Founder
Tara Sullivan
Tara Sullivan
Principal and director
DF
Dave Fielding
Director and promoter

Sources

  1. SECAtlas Oncology Holdings Inc. filing history
  2. CompanyAtlas Oncology Partners Series A announcement
  3. InvestorFlare Capital Partners: Atlas Oncology Partners